APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Decoagulant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Decoagulant Industry Growth and Trends Forecast to 2032

Report ID 173982720127 December 2025106 pages

Choose your research edition.

Industry ResearchDecoagulant Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Decoagulant Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Decoagulant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decoagulant Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Decoagulant Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Decoagulant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Decoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Decoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decoagulant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Decoagulant include Sanofi, Johnson & Johnson, Pfizer, Bayer, AstraZeneca, The Medicines Company, Otsuka, Lilly and Genentech (Roche), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Decoagulant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Decoagulant market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Decoagulant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Decoagulant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Decoagulant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Decoagulant Market by Company

Sanofi

Johnson & Johnson

Pfizer

Bayer

AstraZeneca

The Medicines Company

Otsuka

Lilly

Genentech (Roche)

Daiichi Sankyo

Bristol-Myers Squibb

Boehringer Ingelheim

Aspen

Decoagulant Segment by Type

Low-molecular-weight Heparin (LMWH)

Vitamin K antagonists (VKA)

Platelet aggregation inhibitors (PAI)

Direct thrombin inhibitor (DTI)

Direct factor Xa inhibitors (DFXa)

Others

Decoagulant Segment by Application

VTE

ACS/MI

AF

Others

Decoagulant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decoagulant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decoagulant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decoagulant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Decoagulant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Decoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Low-molecular-weight Heparin (LMWH) Table 2. Major Company of Vitamin K antagonists (VKA) Table 3. Major Company of Platelet aggregation inhibitors (PAI) Table 4. Major Company of Direct thrombin inhibitor (DTI) Table 5. Major Company of Direct factor Xa inhibitors (DFXa) Table 6. Major Company of Others Table 7. Global Decoagulant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Decoagulant Sales by Type (2021-2026) & (W Units) Table 9. Global Decoagulant Sales Market Share in Volume by Type (2021-2026) Table 10. Global Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 11. Global Decoagulant Sales Market Share in Value by Type (2021-2026) Table 12. Global Decoagulant Price by Type (2021-2026) & (US$/Unit) Table 13. Global Decoagulant Sales by Type (2027-2032) & (W Units) Table 14. Global Decoagulant Sales Market Share in Volume by Type (2027-2032) Table 15. Global Decoagulant Sales by Type (2027-2032) & (US$ Million) Table 16. Global Decoagulant Sales Market Share in Value by Type (2027-2032) Table 17. Global Decoagulant Price by Type (2027-2032) & (US$/Unit) Table 18. North America Decoagulant Sales by Type (2021-2026) & (W Units) Table 19. North America Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Decoagulant Sales by Type (2021-2026) & (W Units) Table 21. Europe Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Decoagulant Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Decoagulant Sales by Type (2021-2026) & (W Units) Table 25. Latin America Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Decoagulant Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Decoagulant Sales by Type (2021-2026) & (US$ Million) Table 28. Decoagulant Industry Trends Table 29. Decoagulant Industry Drivers Table 30. Decoagulant Industry Opportunities and Challenges Table 31. Decoagulant Industry Restraints Table 32. Global Decoagulant Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Decoagulant Revenue Market Share by Company (2021-2026) Table 34. Global Decoagulant Sales by Company (2021-2026) & (W Units) Table 35. Global Decoagulant Sales Share by Company (2021-2026) Table 36. Global Decoagulant Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Decoagulant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Decoagulant Major Company Production Sites and Headquarters Table 39. Global Decoagulant Company, Product Type & Application Table 40. Global Decoagulant Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Decoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Decoagulant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Decoagulant Sales by Region (2021-2026) & (W Units) Table 45. Global Decoagulant Sales Market Share in Volume by Region (2021-2026) Table 46. Global Decoagulant Sales by Region (2021-2026) & (US$ Million) Table 47. Global Decoagulant Sales Market Share in Value by Region (2021-2026) Table 48. Global Decoagulant Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Decoagulant Sales by Region (2027-2032) & (W Units) Table 50. Global Decoagulant Sales Market Share in Volume by Region (2027-2032) Table 51. Global Decoagulant Sales by Region (2027-2032) & (US$ Million) Table 52. Global Decoagulant Sales Market Share in Value by Region (2027-2032) Table 53. Global Decoagulant Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Decoagulant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Decoagulant Sales by Application (2021-2026) & (W Units) Table 56. Global Decoagulant Sales Market Share in Volume by Application (2021-2026) Table 57. Global Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 58. Global Decoagulant Sales Market Share in Value by Application (2021-2026) Table 59. Global Decoagulant Price by Application (2021-2026) & (US$/Unit) Table 60. Global Decoagulant Sales by Application (2027-2032) & (W Units) Table 61. Global Decoagulant Sales Market Share in Volume by Application (2027-2032) Table 62. Global Decoagulant Sales by Application (2027-2032) & (US$ Million) Table 63. Global Decoagulant Sales Market Share in Value by Application (2027-2032) Table 64. Global Decoagulant Price by Application (2027-2032) & (US$/Unit) Table 65. North America Decoagulant Sales by Application (2021-2026) & (W Units) Table 66. North America Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Decoagulant Sales by Application (2021-2026) & (W Units) Table 68. Europe Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Decoagulant Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Decoagulant Sales by Application (2021-2026) & (W Units) Table 72. Latin America Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Decoagulant Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Decoagulant Sales by Application (2021-2026) & (US$ Million) Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sanofi Decoagulant Product Portfolio Table 79. Sanofi Recent Development Table 80. Johnson & Johnson Company Information Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Johnson & Johnson Decoagulant Product Portfolio Table 84. Johnson & Johnson Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Decoagulant Product Portfolio Table 89. Pfizer Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bayer Decoagulant Product Portfolio Table 94. Bayer Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. AstraZeneca Decoagulant Product Portfolio Table 99. AstraZeneca Recent Development Table 100. The Medicines Company Company Information Table 101. The Medicines Company Business Overview Table 102. The Medicines Company Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. The Medicines Company Decoagulant Product Portfolio Table 104. The Medicines Company Recent Development Table 105. Otsuka Company Information Table 106. Otsuka Business Overview Table 107. Otsuka Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Otsuka Decoagulant Product Portfolio Table 109. Otsuka Recent Development Table 110. Lilly Company Information Table 111. Lilly Business Overview Table 112. Lilly Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Lilly Decoagulant Product Portfolio Table 114. Lilly Recent Development Table 115. Genentech (Roche) Company Information Table 116. Genentech (Roche) Business Overview Table 117. Genentech (Roche) Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Genentech (Roche) Decoagulant Product Portfolio Table 119. Genentech (Roche) Recent Development Table 120. Daiichi Sankyo Company Information Table 121. Daiichi Sankyo Business Overview Table 122. Daiichi Sankyo Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Daiichi Sankyo Decoagulant Product Portfolio Table 124. Daiichi Sankyo Recent Development Table 125. Bristol-Myers Squibb Company Information Table 126. Bristol-Myers Squibb Business Overview Table 127. Bristol-Myers Squibb Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Bristol-Myers Squibb Decoagulant Product Portfolio Table 129. Bristol-Myers Squibb Recent Development Table 130. Boehringer Ingelheim Company Information Table 131. Boehringer Ingelheim Business Overview Table 132. Boehringer Ingelheim Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Boehringer Ingelheim Decoagulant Product Portfolio Table 134. Boehringer Ingelheim Recent Development Table 135. Aspen Company Information Table 136. Aspen Business Overview Table 137. Aspen Decoagulant Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Aspen Decoagulant Product Portfolio Table 139. Aspen Recent Development Table 140. North America Decoagulant Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. North America Decoagulant Sales by Country (2021-2026) & (W Units) Table 142. North America Decoagulant Sales Market Share by Country (2021-2026) Table 143. North America Decoagulant Sales Forecast by Country (2027-2032) & (W Units) Table 144. North America Decoagulant Sales Market Share Forecast by Country (2027-2032) Table 145. North America Decoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. North America Decoagulant Market Size by Country (2021-2026) & (US$ Million) Table 147. North America Decoagulant Market Share by Country (2021-2026) Table 148. North America Decoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. North America Decoagulant Market Share Forecast by Country (2027-2032) Table 150. Europe Decoagulant Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Europe Decoagulant Sales by Country (2021-2026) & (W Units) Table 152. Europe Decoagulant Sales Market Share by Country (2021-2026) Table 153. Europe Decoagulant Sales Forecast by Country (2027-2032) & (W Units) Table 154. Europe Decoagulant Sales Market Share Forecast by Country (2027-2032) Table 155. Europe Decoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Europe Decoagulant Market Size by Country (2021-2026) & (US$ Million) Table 157. Europe Decoagulant Market Share by Country (2021-2026) Table 158. Europe Decoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Europe Decoagulant Market Share Forecast by Country (2027-2032) Table 160. Asia-Pacific Decoagulant Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Asia-Pacific Decoagulant Sales by Country (2021-2026) & (W Units) Table 162. Asia-Pacific Decoagulant Sales Market Share by Country (2021-2026) Table 163. Asia-Pacific Decoagulant Sales Forecast by Country (2027-2032) & (W Units) Table 164. Asia-Pacific Decoagulant Sales Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Decoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Decoagulant Market Size by Country (2021-2026) & (US$ Million) Table 167. Asia-Pacific Decoagulant Market Share by Country (2021-2026) Table 168. Asia-Pacific Decoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Asia-Pacific Decoagulant Market Share Forecast by Country (2027-2032) Table 170. Latin America Decoagulant Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 171. Latin America Decoagulant Sales by Country (2021-2026) & (W Units) Table 172. Latin America Decoagulant Sales Market Share by Country (2021-2026) Table 173. Latin America Decoagulant Sales Forecast by Country (2027-2032) & (W Units) Table 174. Latin America Decoagulant Sales Market Share Forecast by Country (2027-2032) Table 175. Latin America Decoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Latin America Decoagulant Market Size by Country (2021-2026) & (US$ Million) Table 177. Latin America Decoagulant Market Share by Country (2021-2026) Table 178. Latin America Decoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Latin America Decoagulant Market Share Forecast by Country (2027-2032) Table 180. Middle East and Africa Decoagulant Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 181. Middle East and Africa Decoagulant Sales by Country (2021-2026) & (W Units) Table 182. Middle East and Africa Decoagulant Sales Market Share by Country (2021-2026) Table 183. Middle East and Africa Decoagulant Sales Forecast by Country (2027-2032) & (W Units) Table 184. Middle East and Africa Decoagulant Sales Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Decoagulant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Decoagulant Market Size by Country (2021-2026) & (US$ Million) Table 187. Middle East and Africa Decoagulant Market Share by Country (2021-2026) Table 188. Middle East and Africa Decoagulant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 189. Middle East and Africa Decoagulant Market Share Forecast by Country (2027-2032) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Decoagulant Distributors List Table 193. Decoagulant Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Decoagulant Image Figure 2. Global Decoagulant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decoagulant Market Size (2021-2032) & (US$ Million) Figure 4. Global Decoagulant Sales (2021-2032) & (W Units) Figure 5. Low-molecular-weight Heparin (LMWH) Image Figure 6. Global Low-molecular-weight Heparin (LMWH) Sales YoY Growth (2021-2032) & (W Units) Figure 7. Vitamin K antagonists (VKA) Image Figure 8. Global Vitamin K antagonists (VKA) Sales YoY Growth (2021-2032) & (W Units) Figure 9. Platelet aggregation inhibitors (PAI) Image Figure 10. Global Platelet aggregation inhibitors (PAI) Sales YoY Growth (2021-2032) & (W Units) Figure 11. Direct thrombin inhibitor (DTI) Image Figure 12. Global Direct thrombin inhibitor (DTI) Sales YoY Growth (2021-2032) & (W Units) Figure 13. Direct factor Xa inhibitors (DFXa) Image Figure 14. Global Direct factor Xa inhibitors (DFXa) Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Decoagulant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Decoagulant Market Share by Type 2025 VS 2032 Figure 19. North America Decoagulant Sales Market Share in Volume by Type in 2025 Figure 20. North America Decoagulant Sales Market Share in Value by Type in 2025 Figure 21. Europe Decoagulant Sales Market Share in Volume by Type in 2025 Figure 22. Europe Decoagulant Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Decoagulant Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Decoagulant Sales Market Share in Value by Type in 2025 Figure 25. Latin America Decoagulant Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Decoagulant Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Decoagulant Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Decoagulant Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Decoagulant Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. VTE Image Figure 32. Global VTE Sales YoY Growth (2021-2032) & (W Units) Figure 33. ACS/MI Image Figure 34. Global ACS/MI Sales YoY Growth (2021-2032) & (W Units) Figure 35. AF Image Figure 36. Global AF Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Decoagulant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Decoagulant Market Share by Application 2025 VS 2032 Figure 41. North America Decoagulant Sales Market Share in Volume by Application in 2025 Figure 42. North America Decoagulant Sales Market Share in Value by Application in 2025 Figure 43. Europe Decoagulant Sales Market Share in Volume by Application in 2025 Figure 44. Europe Decoagulant Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Decoagulant Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Decoagulant Sales Market Share in Value by Application in 2025 Figure 47. Latin America Decoagulant Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Decoagulant Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Decoagulant Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Decoagulant Sales Market Share in Value by Application in 2025 Figure 51. North America Decoagulant Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Decoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Decoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Decoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Decoagulant Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Decoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Decoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Decoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Decoagulant Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Decoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Decoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Decoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Decoagulant Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Decoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Decoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Decoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Decoagulant Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Decoagulant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Decoagulant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Decoagulant Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Decoagulant Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Decoagulant Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Low-molecular-weight Heparin (LMWH)
  • Vitamin K antagonists (VKA)
  • Platelet aggregation inhibitors (PAI)
  • Direct thrombin inhibitor (DTI)
  • Direct factor Xa inhibitors (DFXa)
  • Others
Applications
  • VTE
  • ACS/MI
  • AF
  • Others
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Bayer
  • AstraZeneca
  • The Medicines Company
  • Otsuka
  • Lilly
  • Genentech (Roche)
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Aspen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Decoagulant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Decoagulant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Decoagulant Market by Type
  6. 1.3.1 Low-molecular-weight Heparin (LMWH)
  7. 1.3.2 Vitamin K antagonists (VKA)
  8. 1.3.3 Platelet aggregation inhibitors (PAI)
  9. 1.3.4 Direct thrombin inhibitor (DTI)
  10. 1.3.5 Direct factor Xa inhibitors (DFXa)
  11. 1.3.6 Others
  12. 1.4 Global Decoagulant Market Size by Type
  13. 1.4.1 Global Decoagulant Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Decoagulant Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Decoagulant Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Decoagulant Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Decoagulant Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Decoagulant Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Decoagulant Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Decoagulant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Decoagulant Industry Trends
  2. 2.2 Decoagulant Industry Drivers
  3. 2.3 Decoagulant Industry Opportunities and Challenges
  4. 2.4 Decoagulant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Decoagulant Revenue (2021-2026)
  2. 3.2 Global Top Players by Decoagulant Sales (2021-2026)
  3. 3.3 Global Top Players by Decoagulant Price (2021-2026)
  4. 3.4 Global Decoagulant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Decoagulant Major Company Production Sites & Headquarters
  6. 3.6 Global Decoagulant Company, Product Type & Application
  7. 3.7 Global Decoagulant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Decoagulant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Decoagulant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Decoagulant Tier 1, Tier 2, and Tier 3
4 Decoagulant Regional Status and Outlook
  1. 4.1 Global Decoagulant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Decoagulant Historic Market Size by Region
  3. 4.2.1 Global Decoagulant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Decoagulant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Decoagulant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Decoagulant Forecasted Market Size by Region
  7. 4.3.1 Global Decoagulant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Decoagulant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Decoagulant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Decoagulant by Application
  1. 5.1 Decoagulant Market by Application
  2. 5.1.1 VTE
  3. 5.1.2 ACS/MI
  4. 5.1.3 AF
  5. 5.1.4 Others
  6. 5.2 Global Decoagulant Market Size by Application
  7. 5.2.1 Global Decoagulant Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Decoagulant Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Decoagulant Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Decoagulant Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Decoagulant Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Decoagulant Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Decoagulant Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Decoagulant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Decoagulant Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Decoagulant Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Decoagulant Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Decoagulant Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Decoagulant Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 The Medicines Company
  32. 6.6.1 The Medicines Company Company Information
  33. 6.6.2 The Medicines Company Business Overview
  34. 6.6.3 The Medicines Company Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 The Medicines Company Decoagulant Product Portfolio
  36. 6.6.5 The Medicines Company Recent Developments
  37. 6.7 Otsuka
  38. 6.7.1 Otsuka Company Information
  39. 6.7.2 Otsuka Business Overview
  40. 6.7.3 Otsuka Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Otsuka Decoagulant Product Portfolio
  42. 6.7.5 Otsuka Recent Developments
  43. 6.8 Lilly
  44. 6.8.1 Lilly Company Information
  45. 6.8.2 Lilly Business Overview
  46. 6.8.3 Lilly Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lilly Decoagulant Product Portfolio
  48. 6.8.5 Lilly Recent Developments
  49. 6.9 Genentech (Roche)
  50. 6.9.1 Genentech (Roche) Company Information
  51. 6.9.2 Genentech (Roche) Business Overview
  52. 6.9.3 Genentech (Roche) Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Genentech (Roche) Decoagulant Product Portfolio
  54. 6.9.5 Genentech (Roche) Recent Developments
  55. 6.10 Daiichi Sankyo
  56. 6.10.1 Daiichi Sankyo Company Information
  57. 6.10.2 Daiichi Sankyo Business Overview
  58. 6.10.3 Daiichi Sankyo Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Daiichi Sankyo Decoagulant Product Portfolio
  60. 6.10.5 Daiichi Sankyo Recent Developments
  61. 6.11 Bristol-Myers Squibb
  62. 6.11.1 Bristol-Myers Squibb Company Information
  63. 6.11.2 Bristol-Myers Squibb Business Overview
  64. 6.11.3 Bristol-Myers Squibb Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Decoagulant Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Decoagulant Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Aspen
  74. 6.13.1 Aspen Company Information
  75. 6.13.2 Aspen Business Overview
  76. 6.13.3 Aspen Decoagulant Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Aspen Decoagulant Product Portfolio
  78. 6.13.5 Aspen Recent Developments
7 North America by Country
  1. 7.1 North America Decoagulant Sales by Country
  2. 7.1.1 North America Decoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Decoagulant Sales by Country (2021-2026)
  4. 7.1.3 North America Decoagulant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Decoagulant Market Size by Country
  6. 7.2.1 North America Decoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Decoagulant Market Size by Country (2021-2026)
  8. 7.2.3 North America Decoagulant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Decoagulant Sales by Country
  2. 8.1.1 Europe Decoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Decoagulant Sales by Country (2021-2026)
  4. 8.1.3 Europe Decoagulant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Decoagulant Market Size by Country
  6. 8.2.1 Europe Decoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Decoagulant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Decoagulant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Decoagulant Sales by Country
  2. 9.1.1 Asia-Pacific Decoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Decoagulant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Decoagulant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Decoagulant Market Size by Country
  6. 9.2.1 Asia-Pacific Decoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Decoagulant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Decoagulant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Decoagulant Sales by Country
  2. 10.1.1 South America Decoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Decoagulant Sales by Country (2021-2026)
  4. 10.1.3 South America Decoagulant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Decoagulant Market Size by Country
  6. 10.2.1 South America Decoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Decoagulant Market Size by Country (2021-2026)
  8. 10.2.3 South America Decoagulant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Decoagulant Sales by Country
  2. 11.1.1 Middle East and Africa Decoagulant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Decoagulant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Decoagulant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Decoagulant Market Size by Country
  6. 11.2.1 Middle East and Africa Decoagulant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Decoagulant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Decoagulant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Decoagulant Value Chain Analysis
  2. 12.1.1 Decoagulant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Decoagulant Production Mode & Process
  7. 12.2 Decoagulant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Decoagulant Distributors
  10. 12.2.3 Decoagulant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst